SMTI News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

SM

Mkt Cap

$304.6M

Volume

736.90K

Next Earnings

November 11th

Loading chart

SM

SMTISanara MedTech Inc. Common Stock

SMTI

Pay with—

Available Balance0.00

SM

Mkt Cap

$322.4M

Volume

736.90K

Next Earnings

November 11th

Chart Financials Earnings News About Dividends Insider Filings

MIMEDX to Participate in Upcoming Investor ConferencesMIMEDX Group reported second quarter 2026 net sales of $64 million and reiterated its full year financial outlook. The company announced plans to acquire Sanara MedTech in a transformational combination aimed at creating a leading regenerative medicine company and expanding MIMEDX's surgical footprint across multiple surgical subspecialties.GlobeNewswire Inc. · Sep 8, 2026

Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their ShareholdersHalper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether insiders are receiving substantial benefits unavailable to ordinary shareholders and whether transaction terms limit competing offers. The investigations cover Forte Biosciences' sale to argenx, Luxfer Holdings' sale to Wynnchurch Capital affiliates, Sanara MedTech's sale to MiMedx Group, and MarketAxess Holdings' sale to Intercontinental Exchange.GlobeNewswire Inc. · Aug 5, 2026

Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their ShareholdersHalper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.GlobeNewswire Inc. · Aug 4, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.GlobeNewswire Inc. · Jul 30, 2026

Sanara MedTech (SMTI) Q1 2026 Earnings TranscriptSanara MedTech reported strong Q1 2026 results with 19% year-over-year revenue growth to $27.8 million, driven by increased sales of soft tissue repair products CellerateRX and BIASURGE. The company achieved GAAP net profitability with $0.4 million net income ($0.04 per diluted share), improved gross margins to 93%, and paid debt service entirely in cash for the first time. Management maintained full-year 2026 guidance of $116-121 million revenue (13-17% growth) and expects OsStic synthetic bioadhesive product launch in Q1 2027.The Motley Fool · Jun 2, 2026

SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law FirmThe Schall Law Firm is investigating Sanara MedTech Inc. for potential securities fraud related to the discontinuation of its Tissue Health Plus program announced on November 11, 2025. The company reported a $31.2 million net loss from discontinued operations, including a $26.5 million charge for the THP program, causing shares to fall 24.7%. Investors are invited to participate in the investigation.GlobeNewswire Inc. · May 8, 2026

INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLCHolzer & Holzer, LLC is investigating potential federal securities law violations by Sanara MedTech after the company announced a strategic business realignment that resulted in a stock price drop.GlobeNewswire Inc. · Nov 24, 2025

Sanara MedTech Sales Jump 28 PercentSanara MedTech reported Q2 2025 earnings with 28% revenue growth, driven by surgical segment performance. The company's value-based care segment (Tissue Health Plus) continues to face challenges, prompting a strategic review.The Motley Fool · Aug 13, 2025

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.Biomimetic Innovations Ltd, an affiliate of PBC Biomed, has announced an exclusive license and distribution agreement with Sanara MedTech Inc. for the company's OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler. Sanara has also made a minority investment in Biomimetic Innovations Ltd.GlobeNewswire Inc. · Jan 24, 2025

Wound Cleanser Product Market to Surpass US$ 2.24 Billion, Expanding at a 1.4% CAGR by 2034: Fact.MRThe global wound cleanser product market is estimated to reach $2.24 billion by 2034, driven by the growing elderly population, traumatic injuries, surgical procedures, and obesity/diabetes leading to an increase in acute, chronic, and surgical wounds. Technological advancements in wound cleanser formulations have also contributed to market growth.GlobeNewswire Inc. · Sep 25, 2024

to start trading

SM

SMTISanara MedTech Inc. Common Stock

SMTI

Pay with—

Available Balance0.00

Your PositionYou don't own any SMTI yet.

Related Tickers

Earnings

Dividends

Ex Jul 29

Amount$33.00